| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |